Abstract Viridans Group Streptococci (VGS) are associated with high mortality rates in febrile
neutropenia; yet there are no recent European pediatric studies to inform antimicrobial …

Viridans group streptococci (VGS) are major pathogens among children with cancer or
receiving hematopoietic stem cell transplantation and are associated with considerable …

The authors discuss the morbidity associated with viridans streptococcus bacteremia, and its
implications on the choice of antibiotics used as prophylaxis and treatment. They …

Purpose This retrospective study was performed in order to investigate the clinical
characteristics and antibiotic susceptibility of viridans streptococcal bacteremia (VSB) in …

Background: Viridans group streptococci (VGS) cause significant morbidity in children
treated for acute myeloid leukemia (AML). Our goals were to determine the occurrence and …

Viridans group Streptococcus (VGS) is a leading cause of bacteremia in pediatric oncology
patients, primarily in children with acute myeloid leukemia or after hematopoietic stem cell …

Background and Purpose: Viridans streptococci (VS) are part of the normal flora of humans,
but are fast emerging as pathogens causing bacteremia in neutropenic patients. The clinical …

Infection with viridans group streptococci (VGS) causes morbidity and mortality in children
with cancer. Incidence of these infections has increased over time. Neutropenic patients with …

Background This study was performed to compare the clinical characteristics and antibiotic
susceptibilities of viridans streptococcal bacteremia (VSB) between febrile neutropenic …

Background Infections remain an important cause of morbidity and mortality in children with
acute myeloid leukemia (AML), and particularly viridans group streptococci (VGS) sepsis …